07/28/2025
11:43 AM | Kairos Pharma (Filer)
| Form 10-K/A | |
07/15/2025
8:11 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
7:20 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2025
2:38 PM | Kairos Pharma (Filer)
| Form DEFR14A | |
05/15/2025
2:19 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kairos Pharma (Subject)
| Form SCHEDULE 13G | |
05/14/2025
5:34 AM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2025
11:20 AM | Kairos Pharma (Filer)
| Form PRER14A | |
04/28/2025
4:28 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
4:13 PM | Kairos Pharma (Filer)
| Form 424B3 | |
04/24/2025
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
04/24/2025
7:30 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KAPA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kairos Pharma and its competitors with MarketBeat's FREE daily newsletter. |
04/21/2025
6:09 PM | Kairos Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/15/2025
4:30 PM | Kairos Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/07/2025
7:30 AM | Bhowmick Neil (Reporting)
Kairos Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
6:30 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
6:05 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
5:51 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:52 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
3:45 PM | Kairos Pharma (Filer)
| Form DEF 14C | |
02/06/2025
8:00 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
02/05/2025
5:15 AM | Kairos Pharma (Filer)
| Form 424B3 | |
01/29/2025
6:22 AM | Kairos Pharma (Filer)
| Form PRE 14C | |
01/29/2025
5:39 AM | Kairos Pharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/17/2025
4:20 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
8:41 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
7:30 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
5:03 AM | Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
8:53 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:48 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
1:19 PM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:30 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:29 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:10 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:17 PM | Kairos Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/24/2024
8:00 PM | Bae Hyun W. (Reporting)
Kairos Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Keyoung Hansoo Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
MAZANET ROSEMARY (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
The End of Elon Musk…? (Ad) The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. Click here to see why the "End of Elon" crowd is about to be wrong again. |
09/24/2024
8:00 PM | Bhowmick Neil (Reporting)
Kairos Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
3:22 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
3:15 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:36 AM | Kairos Pharma (Filer)
| Form 424B4 | |
09/16/2024
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
09/12/2024
12:57 PM | Kairos Pharma (Filer)
| Form CERT | |
09/12/2024
11:44 AM | Kairos Pharma (Filer)
| Form 8-A12B | |
08/16/2024
4:30 PM | Kairos Pharma (Filer)
| Form S-1/A | |
